A method for simple and accurate identification of the multiple sclerosis associated allele HLA-DRB1*1501 in neuroscience research laboratories

J Neuroimmunol. 2010 Aug 25;225(1-2):143-8. doi: 10.1016/j.jneuroim.2010.03.019. Epub 2010 May 21.

Abstract

Research on multiple sclerosis (MS) frequently requires typing for allele HLA-DRB1*1501, which the complexities of the HLA system can restrict to specialised histocompatibility laboratories. To overcome this limitation, we have implemented a simple, robust and highly specific method for DRB1*1501 detection. One single-tube polymerase-chain reaction (PCR) per DNA sample allows for detecting DR2 individuals. The spare PCR products of these are then sequenced to identify allele DRB1*1501 by comparison with the official, publicly accessible HLA database. This approach, much simpler than previously available methods, should facilitate research on MS by making accurate identification of DRB1*1501 accessible to neuroscience laboratories.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Databases, Genetic / statistics & numerical data
  • Genetic Predisposition to Disease
  • Genetic Testing / methods*
  • HLA-DR Antigens / genetics*
  • HLA-DR2 Antigen / genetics
  • HLA-DRB1 Chains
  • Histocompatibility Testing / methods*
  • Humans
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / genetics*
  • Polymerase Chain Reaction / methods
  • Sensitivity and Specificity
  • Sequence Analysis, DNA / methods

Substances

  • HLA-DR Antigens
  • HLA-DR2 Antigen
  • HLA-DRB1 Chains
  • HLA-DRB1*15 antigen